Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of hormonal contraception on HPA-axis functioning
2012-005640-14Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Microgynon 30, ethinylestradiol + levonorgestrel, desogestrel and avatrombopag (3 arms), sponsored by Erasmus MC. Primary endpoint: Serum HPA-axis hormone levels during ACTH stimulation. Started Apr 2013; status: completed.
02
Drugs
Microgynon 30ethinylestradiol + levonorgestreldesogestrelavatrombopag
Beyond the preview
Go deeper on 2012-005640-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005640-14.